Novartis seeks ways to cut US prices, admitting Americans ‘pay for a large part of the innovations’
Amid a threat of towering US tariffs, Swiss pharmaceutical giant Novartis is seeking ways to enable Americans to pay less for their medicines, its chief said in an interview published Saturday. Vasant Narasimhan told the Swiss daily Neue Zurcher Zeitung (NZZ) that his company was “working to eliminate the price gap between the US and … Read more